Pedro Barata, MD, MSc
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer (NCT07608718) | Pedro Barata, MD, MSc | 2026-09-01 |
| Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer (NCT06312670) | Pedro Barata, MD, MSc | 2024-05-16 |
Track Pedro Barata, MD, MSc automatically
Every clearance here is in the API, with alerts when new ones post.